×

Register now for full access to all the content

First Name
Last Name
Company
Title
Country
Thank you for registering!
Error - something went wrong!
   

3 Important Considerations Of Cardiovascular Outcomes Trials

August 25, 2017

Recently, many sponsors have experienced rising demand from regulators and payers to carry out cardiovascular outcomes trials (CVOT), not only for mandated for type 2 diabetes products but increasingly for other diseases and indications. This infographic addresses some of the frequently asked questions surrounding CVOTs presented from a former Cardiovascular Safety Outcome Trials Think Tank Meeting.

Have you considered:

  • If you need a CVOT to support your product journey?
  • What are the key considerations for performing a CVOT?
  • When should a CVOT be carried out?
Previous Flipbook
Gaining Regulatory & Payer Approval: Five Benefits Of Building A Robust Evidence Platform
Gaining Regulatory & Payer Approval: Five Benefits Of Building A Robust Evidence Platform

Find out how to build a robust evidence package here!

Next Flipbook
3 Steps To A Successful Expanded Access Program
3 Steps To A Successful Expanded Access Program

Find out more about Expanded or Managed Access Programs.